ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide-based Generics Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-32J16098
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide based Generics Market Research Report 2023
BUY CHAPTERS

Global Peptide-based Generics Market Research Report 2025

Code: QYRE-Auto-32J16098
Report
June 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bachem
PolyPeptide
AmbioPharm
CordenPharma
USV Peptides
ScinoPharm
Piramal Pharma Solutions
CPC Scientific
Dr. Reddy’s Laboratories
Omgene Life Sciences
AnyGen Co.
BCN Peptides
Amphastar Pharmaceuticals

Peptide-based Generics Market Size

The global market for Peptide-based Generics was valued at US$ 1831 million in the year 2024 and is projected to reach a revised size of US$ 2828 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Peptide-based Generics Market

Peptide-based Generics Market

Peptide-based generics refer to pharmaceutical products that are generic versions of brand-name drugs or biologics that are based on peptides as their active ingredients. Peptides are short chains of amino acids, and peptide-based drugs are used to treat a wide range of medical conditions, including diabetes, autoimmune disorders, and cancer.
Peptide-based generics represent a burgeoning sector in the pharmaceutical industry with a gradually expanding market size. These drugs, by mimicking the structure and functionality of natural peptides, have successfully replicated original medications, achieving notable sales across various therapeutic areas. The specific uses of peptide-based generics are concentrated in treating conditions such as cancer, diabetes, and autoimmune diseases, spanning a wide range of medical fields. Looking ahead, the future development of peptide-based generics holds the promise of playing a more significant role in new drug research and development, offering patients a broader spectrum of treatment options.
This report aims to provide a comprehensive presentation of the global market for Peptide-based Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-based Generics.
The Peptide-based Generics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide-based Generics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-based Generics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide-based Generics Market Report

Report Metric Details
Report Name Peptide-based Generics Market
Accounted market size in year US$ 1831 million
Forecasted market size in 2031 US$ 2828 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hormone Analogs
  • Vasopressin Analogs
  • Calcitonin Generics
  • Other
Segment by Application
  • Commercial Production
  • Scientific Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bachem, PolyPeptide, AmbioPharm, CordenPharma, USV Peptides, ScinoPharm, Piramal Pharma Solutions, CPC Scientific, Dr. Reddy's Laboratories, Omgene Life Sciences, ANYGEN, BCN Peptides, Amphastar Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide-based Generics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide-based Generics Market growing?

Ans: The Peptide-based Generics Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Peptide-based Generics Market size in 2031?

Ans: The Peptide-based Generics Market size in 2031 will be US$ 2828 million.

Who are the main players in the Peptide-based Generics Market report?

Ans: The main players in the Peptide-based Generics Market are Bachem, PolyPeptide, AmbioPharm, CordenPharma, USV Peptides, ScinoPharm, Piramal Pharma Solutions, CPC Scientific, Dr. Reddy's Laboratories, Omgene Life Sciences, ANYGEN, BCN Peptides, Amphastar Pharmaceuticals

What are the Application segmentation covered in the Peptide-based Generics Market report?

Ans: The Applications covered in the Peptide-based Generics Market report are Commercial Production, Scientific Research, Other

What are the Type segmentation covered in the Peptide-based Generics Market report?

Ans: The Types covered in the Peptide-based Generics Market report are Hormone Analogs, Vasopressin Analogs, Calcitonin Generics, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Generics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hormone Analogs
1.2.3 Vasopressin Analogs
1.2.4 Calcitonin Generics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Peptide-based Generics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial Production
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Generics Market Perspective (2020-2031)
2.2 Global Peptide-based Generics Growth Trends by Region
2.2.1 Global Peptide-based Generics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide-based Generics Historic Market Size by Region (2020-2025)
2.2.3 Peptide-based Generics Forecasted Market Size by Region (2026-2031)
2.3 Peptide-based Generics Market Dynamics
2.3.1 Peptide-based Generics Industry Trends
2.3.2 Peptide-based Generics Market Drivers
2.3.3 Peptide-based Generics Market Challenges
2.3.4 Peptide-based Generics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-based Generics Players by Revenue
3.1.1 Global Top Peptide-based Generics Players by Revenue (2020-2025)
3.1.2 Global Peptide-based Generics Revenue Market Share by Players (2020-2025)
3.2 Global Peptide-based Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide-based Generics Revenue
3.4 Global Peptide-based Generics Market Concentration Ratio
3.4.1 Global Peptide-based Generics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Generics Revenue in 2024
3.5 Global Key Players of Peptide-based Generics Head office and Area Served
3.6 Global Key Players of Peptide-based Generics, Product and Application
3.7 Global Key Players of Peptide-based Generics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Generics Breakdown Data by Type
4.1 Global Peptide-based Generics Historic Market Size by Type (2020-2025)
4.2 Global Peptide-based Generics Forecasted Market Size by Type (2026-2031)
5 Peptide-based Generics Breakdown Data by Application
5.1 Global Peptide-based Generics Historic Market Size by Application (2020-2025)
5.2 Global Peptide-based Generics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide-based Generics Market Size (2020-2031)
6.2 North America Peptide-based Generics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide-based Generics Market Size by Country (2020-2025)
6.4 North America Peptide-based Generics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-based Generics Market Size (2020-2031)
7.2 Europe Peptide-based Generics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide-based Generics Market Size by Country (2020-2025)
7.4 Europe Peptide-based Generics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-based Generics Market Size (2020-2031)
8.2 Asia-Pacific Peptide-based Generics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide-based Generics Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide-based Generics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-based Generics Market Size (2020-2031)
9.2 Latin America Peptide-based Generics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide-based Generics Market Size by Country (2020-2025)
9.4 Latin America Peptide-based Generics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-based Generics Market Size (2020-2031)
10.2 Middle East & Africa Peptide-based Generics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide-based Generics Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide-based Generics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide-based Generics Introduction
11.1.4 Bachem Revenue in Peptide-based Generics Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide-based Generics Introduction
11.2.4 PolyPeptide Revenue in Peptide-based Generics Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 AmbioPharm
11.3.1 AmbioPharm Company Details
11.3.2 AmbioPharm Business Overview
11.3.3 AmbioPharm Peptide-based Generics Introduction
11.3.4 AmbioPharm Revenue in Peptide-based Generics Business (2020-2025)
11.3.5 AmbioPharm Recent Development
11.4 CordenPharma
11.4.1 CordenPharma Company Details
11.4.2 CordenPharma Business Overview
11.4.3 CordenPharma Peptide-based Generics Introduction
11.4.4 CordenPharma Revenue in Peptide-based Generics Business (2020-2025)
11.4.5 CordenPharma Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Peptide-based Generics Introduction
11.5.4 USV Peptides Revenue in Peptide-based Generics Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 ScinoPharm
11.6.1 ScinoPharm Company Details
11.6.2 ScinoPharm Business Overview
11.6.3 ScinoPharm Peptide-based Generics Introduction
11.6.4 ScinoPharm Revenue in Peptide-based Generics Business (2020-2025)
11.6.5 ScinoPharm Recent Development
11.7 Piramal Pharma Solutions
11.7.1 Piramal Pharma Solutions Company Details
11.7.2 Piramal Pharma Solutions Business Overview
11.7.3 Piramal Pharma Solutions Peptide-based Generics Introduction
11.7.4 Piramal Pharma Solutions Revenue in Peptide-based Generics Business (2020-2025)
11.7.5 Piramal Pharma Solutions Recent Development
11.8 CPC Scientific
11.8.1 CPC Scientific Company Details
11.8.2 CPC Scientific Business Overview
11.8.3 CPC Scientific Peptide-based Generics Introduction
11.8.4 CPC Scientific Revenue in Peptide-based Generics Business (2020-2025)
11.8.5 CPC Scientific Recent Development
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Details
11.9.2 Dr. Reddy's Laboratories Business Overview
11.9.3 Dr. Reddy's Laboratories Peptide-based Generics Introduction
11.9.4 Dr. Reddy's Laboratories Revenue in Peptide-based Generics Business (2020-2025)
11.9.5 Dr. Reddy's Laboratories Recent Development
11.10 Omgene Life Sciences
11.10.1 Omgene Life Sciences Company Details
11.10.2 Omgene Life Sciences Business Overview
11.10.3 Omgene Life Sciences Peptide-based Generics Introduction
11.10.4 Omgene Life Sciences Revenue in Peptide-based Generics Business (2020-2025)
11.10.5 Omgene Life Sciences Recent Development
11.11 ANYGEN
11.11.1 ANYGEN Company Details
11.11.2 ANYGEN Business Overview
11.11.3 ANYGEN Peptide-based Generics Introduction
11.11.4 ANYGEN Revenue in Peptide-based Generics Business (2020-2025)
11.11.5 ANYGEN Recent Development
11.12 BCN Peptides
11.12.1 BCN Peptides Company Details
11.12.2 BCN Peptides Business Overview
11.12.3 BCN Peptides Peptide-based Generics Introduction
11.12.4 BCN Peptides Revenue in Peptide-based Generics Business (2020-2025)
11.12.5 BCN Peptides Recent Development
11.13 Amphastar Pharmaceuticals
11.13.1 Amphastar Pharmaceuticals Company Details
11.13.2 Amphastar Pharmaceuticals Business Overview
11.13.3 Amphastar Pharmaceuticals Peptide-based Generics Introduction
11.13.4 Amphastar Pharmaceuticals Revenue in Peptide-based Generics Business (2020-2025)
11.13.5 Amphastar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bachem
PolyPeptide
AmbioPharm
CordenPharma
USV Peptides
ScinoPharm
Piramal Pharma Solutions
CPC Scientific
Dr. Reddy’s Laboratories
Omgene Life Sciences
AnyGen Co.
BCN Peptides
Amphastar Pharmaceuticals
List of Tables
 Table 1. Global Peptide-based Generics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hormone Analogs
 Table 3. Key Players of Vasopressin Analogs
 Table 4. Key Players of Calcitonin Generics
 Table 5. Key Players of Other
 Table 6. Global Peptide-based Generics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Peptide-based Generics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Peptide-based Generics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Peptide-based Generics Market Share by Region (2020-2025)
 Table 10. Global Peptide-based Generics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Peptide-based Generics Market Share by Region (2026-2031)
 Table 12. Peptide-based Generics Market Trends
 Table 13. Peptide-based Generics Market Drivers
 Table 14. Peptide-based Generics Market Challenges
 Table 15. Peptide-based Generics Market Restraints
 Table 16. Global Peptide-based Generics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Peptide-based Generics Market Share by Players (2020-2025)
 Table 18. Global Top Peptide-based Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Generics as of 2024)
 Table 19. Ranking of Global Top Peptide-based Generics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Peptide-based Generics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Peptide-based Generics, Headquarters and Area Served
 Table 22. Global Key Players of Peptide-based Generics, Product and Application
 Table 23. Global Key Players of Peptide-based Generics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Peptide-based Generics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Peptide-based Generics Revenue Market Share by Type (2020-2025)
 Table 27. Global Peptide-based Generics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Peptide-based Generics Revenue Market Share by Type (2026-2031)
 Table 29. Global Peptide-based Generics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Peptide-based Generics Revenue Market Share by Application (2020-2025)
 Table 31. Global Peptide-based Generics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Peptide-based Generics Revenue Market Share by Application (2026-2031)
 Table 33. North America Peptide-based Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Peptide-based Generics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Peptide-based Generics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Peptide-based Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Peptide-based Generics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Peptide-based Generics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Peptide-based Generics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Peptide-based Generics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Peptide-based Generics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Peptide-based Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Peptide-based Generics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peptide-based Generics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Peptide-based Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Peptide-based Generics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Peptide-based Generics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Bachem Company Details
 Table 49. Bachem Business Overview
 Table 50. Bachem Peptide-based Generics Product
 Table 51. Bachem Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 52. Bachem Recent Development
 Table 53. PolyPeptide Company Details
 Table 54. PolyPeptide Business Overview
 Table 55. PolyPeptide Peptide-based Generics Product
 Table 56. PolyPeptide Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 57. PolyPeptide Recent Development
 Table 58. AmbioPharm Company Details
 Table 59. AmbioPharm Business Overview
 Table 60. AmbioPharm Peptide-based Generics Product
 Table 61. AmbioPharm Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 62. AmbioPharm Recent Development
 Table 63. CordenPharma Company Details
 Table 64. CordenPharma Business Overview
 Table 65. CordenPharma Peptide-based Generics Product
 Table 66. CordenPharma Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 67. CordenPharma Recent Development
 Table 68. USV Peptides Company Details
 Table 69. USV Peptides Business Overview
 Table 70. USV Peptides Peptide-based Generics Product
 Table 71. USV Peptides Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 72. USV Peptides Recent Development
 Table 73. ScinoPharm Company Details
 Table 74. ScinoPharm Business Overview
 Table 75. ScinoPharm Peptide-based Generics Product
 Table 76. ScinoPharm Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 77. ScinoPharm Recent Development
 Table 78. Piramal Pharma Solutions Company Details
 Table 79. Piramal Pharma Solutions Business Overview
 Table 80. Piramal Pharma Solutions Peptide-based Generics Product
 Table 81. Piramal Pharma Solutions Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 82. Piramal Pharma Solutions Recent Development
 Table 83. CPC Scientific Company Details
 Table 84. CPC Scientific Business Overview
 Table 85. CPC Scientific Peptide-based Generics Product
 Table 86. CPC Scientific Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 87. CPC Scientific Recent Development
 Table 88. Dr. Reddy's Laboratories Company Details
 Table 89. Dr. Reddy's Laboratories Business Overview
 Table 90. Dr. Reddy's Laboratories Peptide-based Generics Product
 Table 91. Dr. Reddy's Laboratories Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 92. Dr. Reddy's Laboratories Recent Development
 Table 93. Omgene Life Sciences Company Details
 Table 94. Omgene Life Sciences Business Overview
 Table 95. Omgene Life Sciences Peptide-based Generics Product
 Table 96. Omgene Life Sciences Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 97. Omgene Life Sciences Recent Development
 Table 98. ANYGEN Company Details
 Table 99. ANYGEN Business Overview
 Table 100. ANYGEN Peptide-based Generics Product
 Table 101. ANYGEN Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 102. ANYGEN Recent Development
 Table 103. BCN Peptides Company Details
 Table 104. BCN Peptides Business Overview
 Table 105. BCN Peptides Peptide-based Generics Product
 Table 106. BCN Peptides Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 107. BCN Peptides Recent Development
 Table 108. Amphastar Pharmaceuticals Company Details
 Table 109. Amphastar Pharmaceuticals Business Overview
 Table 110. Amphastar Pharmaceuticals Peptide-based Generics Product
 Table 111. Amphastar Pharmaceuticals Revenue in Peptide-based Generics Business (2020-2025) & (US$ Million)
 Table 112. Amphastar Pharmaceuticals Recent Development
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Peptide-based Generics Picture
 Figure 2. Global Peptide-based Generics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide-based Generics Market Share by Type: 2024 VS 2031
 Figure 4. Hormone Analogs Features
 Figure 5. Vasopressin Analogs Features
 Figure 6. Calcitonin Generics Features
 Figure 7. Other Features
 Figure 8. Global Peptide-based Generics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Peptide-based Generics Market Share by Application: 2024 VS 2031
 Figure 10. Commercial Production Case Studies
 Figure 11. Scientific Research Case Studies
 Figure 12. Other Case Studies
 Figure 13. Peptide-based Generics Report Years Considered
 Figure 14. Global Peptide-based Generics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Peptide-based Generics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Peptide-based Generics Market Share by Region: 2024 VS 2031
 Figure 17. Global Peptide-based Generics Market Share by Players in 2024
 Figure 18. Global Top Peptide-based Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Generics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Peptide-based Generics Revenue in 2024
 Figure 20. North America Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Peptide-based Generics Market Share by Country (2020-2031)
 Figure 22. United States Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Peptide-based Generics Market Share by Country (2020-2031)
 Figure 26. Germany Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Peptide-based Generics Market Share by Region (2020-2031)
 Figure 34. China Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Peptide-based Generics Market Share by Country (2020-2031)
 Figure 42. Mexico Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Peptide-based Generics Market Share by Country (2020-2031)
 Figure 46. Turkey Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Peptide-based Generics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Bachem Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 50. PolyPeptide Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 51. AmbioPharm Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 52. CordenPharma Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 53. USV Peptides Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 54. ScinoPharm Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 55. Piramal Pharma Solutions Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 56. CPC Scientific Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 57. Dr. Reddy's Laboratories Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 58. Omgene Life Sciences Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 59. ANYGEN Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 60. BCN Peptides Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 61. Amphastar Pharmaceuticals Revenue Growth Rate in Peptide-based Generics Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Cancer Therapeutics Market Research Report 2024
Global Peptide Drugs for Diabetes Market Research Report 2024
Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Peptide Drugs Market Research Report 2024
Global Biologic Peptide API Market Research Report 2024
Global Therapeutic Peptide APIs Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Global Peptide Based Vaccines for Cancer Market Research Report 2025
Global Targeting Peptides Market Research Report 2024
Global Peptide based Cosmetics Raw Materials Market Research Report 2024
Global Active Peptide Cosmetics Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Peptide Therapy Market Research Report 2025
Global Protein and Peptide Therapeutics Market Research Report 2025
Global Peptide Supplement Market Research Report 2024
Global High end Generic Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions